US 11072644
Inhibitory chimeric antigen receptors
granted A61KA61K2039/5156A61K2239/21
Quick answer
US patent 11072644 (Inhibitory chimeric antigen receptors) held by Allogene Therapeutics, Inc. expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Allogene Therapeutics, Inc.
- Grant date
- Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/5156, A61K2239/21, A61K2239/29, A61K2239/31